The University of California, Berkeley, and collaborators are contesting the US Patent and Trademark Offices Patent Trial and Appeal Board (PTAB)’s February decision that their own patent application on CRISPR gene-editing technology does not overlap with a patent owned by the Broad Institute of MIT and Harvard .
“Ultimately, we expect to establish definitively that the team led by Jennifer Doudna and Emmanuelle Charpentier was the first to engineer CRISPR-Cas9 for use in all types of environments, including in non-cellular settings and within plant, animal and even human cells,” Edward Penhoet, associate dean of biology at UC Berkeley, said in a statement.
“Given that the facts have not changed, we expect the outcome will once again be the same,” Lee McGuire, chief communications officer at the Broad, said in a statement. “To overturn the PTAB decision, the Court would need to decide that the PTAB committed...
Researchers at Harvard University and the Broad Institute have developed a CRISPR-based diagnostic tool that can decipher Zika virus from dengue, differentiate among bacterial pathogens, and identify single-nucleotide polymorphisms in human DNA. The team described its approach in Science this week (April 13).
With a different type of CRISPR gene editing, scientists at the University of Texas Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy–causing mutations in cultured human muscle cells and in a mouse model. The team published its results in Science Advances this week (April 12).
When scientists at the Karolinska Institute in Sweden and their colleagues reprogrammed glial cells into dopaminergic neurons in the brains of mice exhibiting Parkinson’s-like symptoms, they observed partially restored motor function in the animals. The team published its results in Nature Biotechnology this week (April 10).
In Nature Neuroscience, researchers at the University of Wisconsin–Madison and their colleagues this week (April 10) pinpointed dreaming-associated patterns of brainwave activity in an area of the brain dubbed the “posterior hot zone.”
In mice, aging-related changes in gut microbiome composition are causally linked to intestinal permeability and levels of inflammation, researchers from McMaster University in Hamilton, Ontario, and their colleagues showed in Cell Host & Microbe this week (April 12).